Helix Biopharma Corp. to Present at BIT Life Sciences' Third Annual International Congress of Antibodies in Beijing, China on March 25 – Market Wire

February 17, 2017

AURORA, ON–(Marketwire – March 23, 2011) – Helix BioPharma Corp. (TSX: HBP ) ( NYSE Amex : HBP ) ( FRANKFURT : HBP ), a developer of biopharmaceutical drug candidates for the prevention and treatment of cancer, today announced that Baomin Tian, Ph.D …

Some local news is curated – Original might have been posted at a different date/ time! Click the source link for details.